News
Burrill & Company Announces Close of Burrill Brazil Fund I January 18, 2012 | Press Release
Burrill & Company’s Merchant Banking Group Launches Institutional Equities Research Division with Addition of Jason Zhang, Ph.D., as Senior Research Analyst January 06, 2012 | Press Release
Global Financial Market Turmoil Overshadows Biotech Successes in 2011 January 03, 2012 | Press Release
See all News
Burrill & Company's Institutional Equities business provides institutional clients with seasoned equity advice and capital markets expertise focused on all aspects of the life sciences and biogreentech. Our institutional equities division compliments our merchant banking, private equity, and venture groups by raising capital through public offerings and private placements.
Buy-side relationships; 10b-18 corporate relationships; deep sector expertise
Relationship managers with knowledge of life sciences and biogreentech
Providing clients with direct exposure to industries, companies, and management.
A highly regarded management team with deep expertise across the life sciences offering industry-leading advice.
At the market programs allow companies to tap into the existing secondary market for their shares on an as-and-when-needed basis.